RtxA1 is a major cytotoxin of () causing fatal septicemia and necrotic wound infections. Our previous work has shown that RpoS regulates the expression and secretion of RtxA1 toxin. This study was conducted to further investigate the potential mechanisms of RpoS on RtxA1 secretion. First, TolCV1 and TolCV2 proteins, two TolC homologs, were measured at various time points by Western blotting. The expression of TolCV1 was increased time-dependently, whereas that of TolCV2 was decreased. Expression of both TolCV1 and TolCV2 was significantly downregulated in an deletion mutation. Subsequently, we explored the roles of TolCV1 and TolCV2 in pathogenesis. Western blot analysis showed that RtxA1 toxin was exported by TolCV1, not TolCV2, which was consistent with the cytotoxicity results. Furthermore, the expression of TolCV1 and TolCV2 was increased after treatment of the host signal bile salt and the growth of mutant was totally abolished in the presence of bile salt. A mutation resulted in significant reduction of induced-virulence in mice. Taken together, TolCV1 plays key roles in RtxA1 secretion, bile salt resistance, and mice lethality of , suggesting that TolCV1 could be an attractive target for the design of new medicines to treat infections.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120275 | PMC |
http://dx.doi.org/10.3389/fcimb.2021.673222 | DOI Listing |
Front Cell Infect Microbiol
July 2021
College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, South Korea.
RtxA1 is a major cytotoxin of () causing fatal septicemia and necrotic wound infections. Our previous work has shown that RpoS regulates the expression and secretion of RtxA1 toxin. This study was conducted to further investigate the potential mechanisms of RpoS on RtxA1 secretion.
View Article and Find Full Text PDFJ Microbiol
April 2015
Department of Life Science, Chung-Ang University, Seoul, 156-756, Republic of Korea.
Resistance-nodulation-division (RND) efflux pumps are associated with multidrug resistance in many gram-negative pathogens. The genome of Vibrio vulnificus encodes 11 putative RND pumps homologous to those of Vibrio cholerae and Escherichia coli. In this study, we analyzed three putative RND efflux pumps, showing homology to V.
View Article and Find Full Text PDFCurr Microbiol
June 2014
Department of Life Science, Chung-Ang University, 84 Heuksok-Ro, Dongjak-Gu, Seoul, 156-756, Republic of Korea.
Gram-negative bacteria use tripartite pumps to transport antibacterial drugs and other toxic compounds across the inner and outer membranes, which are separated by the periplasmic space. The TolC protein is an outer membrane factor that participates in the formation of tripartite efflux pumps. The genome of Vibrio vulnificus encodes two E.
View Article and Find Full Text PDFJ Microbiol
February 2014
Department of Life Science, Chung-Ang University, Seoul, 156-756, Republic of Korea.
The AcrAB-TolC multidrug efflux pump confers resistance to Escherichia coli against many antibiotics and toxic compounds. The TolC protein is an outer membrane factor that participates in the formation of type I secretion systems. The genome of Vibrio vulnificus encodes two proteins homologous to the E.
View Article and Find Full Text PDFJ Microbiol
April 2013
Department of Life Science, Chung-Ang University, Seoul 156-756, Republic of Korea.
TolC and its homologous family of proteins are outer membrane factors that are essential for exporting small molecules and toxins across the outer membrane in Gram-negative bacteria. Two open reading frames in the Vibrio vulnificus genome that encode proteins homologous to Escherichia coli TolC, designated TolCV1 and TolCV2, have 51.3% and 29.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!